Construction of MPEG-PCL Nanomicelle Ocular Drug Delivery Vector and Its Application in the Treatment of Hypertensive Fundus Disease

Table 2

Quality of life data analysis table.

	Control group	Test group	Time ()	Significant difference ()
0 day	7.832	7.742	0	1
1-2 days	7.952	7.952	0.85	1.202
3-4 days	8.189	8.256	2.132	1.503
5-6 days	8.426	8.628	5.292	2.232
7-8 days	8.827	9.125	8.513	3.273
9-10 days	8.869	9.256	9.952	1.469
11-12 days	8.912	9.389	11.692	0.662
13-14 days	8.982	9.537	13.5	0.001